Health
Related: About this forumMarijuana derivative reduces seizures in people with treatment-resistant epilepsy
NEW YORK, NY - Cannabidiol (CBD), a medical marijuana derivative, was effective in reducing seizure frequency and well-tolerated and safe for most children and young adults enrolled in a year-long study led by epilepsy specialists at NYU Langone Medical Center.
These latest findings provide the first estimates of safety, tolerability and efficacy of prescription CBD in children and adults with severe, highly treatment-resistant epilepsy. Led by Orrin Devinsky, MD, professor of neurology, neurosurgery, and psychiatry and director of the Comprehensive Epilepsy Center at NYU Langone, the study is published in the December 23 issue of Lancet Neurology. While early findings have been released at medical meetings -- including the 2015 American Academy of Neurology conference -- these are the first findings from the trial to be published in a peer-reviewed journal.
http://www.eurekalert.org/pub_releases/2015-12/nlmc-mdr122315.php
Binkie The Clown
(7,911 posts)mucifer
(23,565 posts)the cost of the medication. It's a pharmaceutical. So a big corporation will be controlling it. How will the government deal with people growing their own product to deal with seizures if they can't afford the medication?
Scuba
(53,475 posts)Never heard of pot giving anyone migraines.